XML 45 R34.htm IDEA: XBRL DOCUMENT v3.25.2
Stock-Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule Of Share Based Compensation Shares Authorized Under Stock Plans Issued And Avaliability Table Text Block
The following table summarizes the number of shares of common stock authorized for issuance under the 2019 Plan, the number of stock-based awards granted (net of expired or cancelled awards) under the 2019 Plan, and the number of shares of common stock available for the grant of stock-based awards under the 2019 Plan:
Common stock authorized(1)
19,000
Stock-based awards, including restricted stock and stock options granted, net of expired or cancelled awards(10,970)
Common stock available for grant of stock-based awards as of June 30, 20258,030
(1) On May 22, 2024, the stockholders of the Company approved amendments to the Steven Madden, Ltd. 2019 Plan to, among other things, increase the number of shares of Company common stock available for issuance under the 2019 Plan. As amended, the 2019 Plan provides that up to a total of 19,000 shares of the Company’s common stock may be issued thereunder.
Share-Based Payment Arrangement, Expensed and Capitalized, Amount
Total equity-based compensation for the three and six months ended June 30, 2025 and 2024 is as follows:
 Three Months Ended June 30,Six Months Ended June 30,
 2025202420252024
Restricted stock$5,793 $5,573 $11,486 $10,765 
Stock options555 603 1,213 1,149 
Performance-based awards1,187 665 1,991 665 
Total$7,535 $6,841 $14,690 $12,579 
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award
Cash proceeds and intrinsic values related to total stock options exercised during the three and six months ended June 30, 2025 and 2024 are as follows:
 Three Months Ended June 30,Six Months Ended June 30,
 2025202420252024
Proceeds from stock options exercised$— $527 $— $749 
Intrinsic value of stock options exercised$— $364 $— $506 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions The following weighted average assumptions were used for stock options granted during the six months ended June 30, 2025 and 2024:
Six Months Ended June 30,
 20252024
Volatility
33.6% to 38.3%
 34.1% to 47.4%
Risk free interest rate
3.7% to 4.3%
4.0% to 4.6%
Expected life in years
3.0 to 4.0
3.0 to 4.0
Dividend yield3.6%2.0%
Weighted average fair value$6.07$13.22
Schedule of Stock Options Roll Forward
Activity relating to stock options granted under the Company’s plans during the six months ended June 30, 2025 was as follows:
 Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual TermAggregate Intrinsic Value
Outstanding at January 1, 20251,268$36.82   
Granted25025.08   
Expired(34)36.10 
Outstanding at June 30, 20251,484$34.86 2.9 years$45 
Exercisable at June 30, 20251,208$36.76 2.2 years$— 
Activity relating to stock options granted under the Company’s plans during the six months ended June 30, 2024 was as follows:
 Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual TermAggregate Intrinsic Value
Outstanding at January 1, 20241,119$35.62   
Granted23341.32   
Exercised(46)32.18   
Expired(2)$46.47 
Outstanding at June 30, 20241,304$36.74 3.2 years$7,687 
Exercisable at June 30, 20241,026$35.59 2.7 years$7,296 
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity
The following table summarizes restricted stock activity during the six months ended June 30, 2025 and 2024:
 20252024
 Number of SharesWeighted Average Fair Value at Grant DateNumber of SharesWeighted Average Fair Value at Grant Date
Outstanding at January 1,1,543$38.89 1,278$35.44 
Granted75832.65 68342.11 
Vested(499)39.20 (312)34.42 
Forfeited(45)36.46 (20)37.09 
Outstanding at June 30,1,757$36.17 1,629$38.39